Hims & Hers Stock Surges As It Collaborates With Novo Nordisk To Sell Weight Loss Drug Wegovy On Its Platform

benzinga.com/25/04/45074872/hims-hers-stock-surges-as-it-collaborates-with-novo-nordisk-to-sell-weight-loss-drug-wegovy-on-its-platform

Novo Nordisk A/S (NYSE:NVO) and Hims & Hers Health, Inc. (NYSE:HIMS) announced a long-term collaboration on Tuesday.
In March, Novo Nordisk introduced NovoCare Pharmacy, a direct-to-patient delivery service to improve access to Wegovy (semaglutide) for cash-paying patients.
Americans can…

This story appeared on benzinga.com, 2025-04-29 16:13:01.
The Entire Business World on a Single Page. Free to Use →